Synthesis of Droloxifene Citrate and its New Bioactivity

Yaoxue Xuebao

Volumn 35, Issue 12, 2000, Pages 904-905

  Chen, Ying ^a   Xia, Peng ^a   Zhang, Qian ^a   Zheng, Yun Hong ^a   Xia, Yi ^b   Yang, Zheng Yu ^b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Corpus luteum cell apoptosis; Droloxifene; Multiple drug resistance

Indexed keywords

3-HYDROXYTAMOXIFEN; ANTINEOPLASTIC AGENT; DOXORUBICIN; DROLOXIFENE; DRUG DERIVATIVE; TAMOXIFEN;

ANIMAL; APOPTOSIS; ARTICLE; CELL STRAIN K 562; CYTOLOGY; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENE; GENE EXPRESSION; HUMAN; LUTEAL CELL; MULTIDRUG RESISTANCE; PHARMACEUTICS; RAT; SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; GENES, MDR; HUMANS; K562 CELLS; LUTEAL CELLS; RATS; TAMOXIFEN; TECHNOLOGY, PHARMACEUTICAL;

EID: 0141500086     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Scheckaneder H. 1,1,2-Triphenyl-but-1-en-Derivate sowie Verfahren zu ihren Herstellung und Ihre Verwandung als Arzneimittel [P]. Eur Pat: 0054168, 1981-10-29.
2. Kawamura I, Mizota T, Mukumoto S, et al. Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma [J]. Arzneimittelforschung, 1989,39(11):889-893.
3. Li J, Xiu LZ, He KL, et al. Modulation of multiple drug resistance by nomegestrol acetate and droloxifene in K562/A02 [J]. Chin J Hematol (in Chinese), 1999, 20 (6):288-291.
4. Leng Y, Yang B, Cao L, et al. Effects of anordrin, droloxifene, nomegestrol, and mofepristone on cultured rat luteal cell apoptosis [J]. Acta Pharmacol Sin (in Chinese), 1999,20(5):400-404.
5. Foster AB, Jarman M, Leung OT, et al. Hydroxy derivatives of tamoxifene [J]. J Med Chem, 1985,28 (10):1491-1497.
6. Elks J, Ganellin CR. Dictionary of Drugs [M]. London: Chapman and Hall, 1990.472.